Yes, letrozole increases testosterone. It does so by blocking the enzyme that converts testosterone into estrogen, which triggers the brain to signal for more testosterone production. This dual effect, less estrogen and more testosterone, is why letrozole has gained attention as a treatment for male infertility, obesity-related low testosterone, and hormonal imbalances in both men and women.
How Letrozole Raises Testosterone
Letrozole belongs to a class of drugs called aromatase inhibitors. Aromatase is the enzyme responsible for converting androgens (like testosterone) into estrogens (like estradiol). Letrozole works by binding to this enzyme and shutting it down, which means less testosterone gets converted into estrogen.
That alone would raise testosterone levels somewhat, since less of it is being used up. But the bigger effect comes from a feedback loop in the brain. Normally, estradiol signals to the hypothalamus and pituitary gland that hormone levels are adequate, keeping production in check. When letrozole suppresses estradiol, the brain reads that as a deficit and responds by releasing more luteinizing hormone (LH) and follicle-stimulating hormone (FSH). LH directly stimulates the testes to produce more testosterone. The result is a significant rise in circulating testosterone alongside a drop in estrogen.
This mechanism is well documented. Men with a genetic inability to produce aromatase (due to mutations in the CYP19 gene) naturally have high gonadotropin and testosterone levels for exactly this reason: without estrogen feedback, the brain keeps pushing testosterone production higher.
How Much Testosterone Increases
The increase is substantial and consistent across studies. In one study of all treated men, total serum testosterone rose and estradiol levels dropped significantly, raising the overall testosterone-to-estradiol ratio (a key marker of hormonal balance) with high statistical confidence.
A pilot study of severely obese men with low testosterone found that just 2.5 mg of letrozole once per week produced a sustained normalization of total testosterone over six months. In fact, free testosterone frequently rose to above-normal levels, prompting the researchers to recommend starting at a lower dose. This is notable because obesity tends to increase aromatase activity (fat tissue produces more of the enzyme), making obese men particularly responsive to aromatase inhibition.
The testosterone-to-estradiol ratio is especially important. In men with infertility, a ratio below 10 is considered a strong indicator that letrozole could help. After treatment, this ratio improves dramatically in virtually all patients.
Effects on Male Fertility
The testosterone increase from letrozole doesn’t just show up on blood tests. It translates into measurable improvements in sperm quality. Studies have found that sperm concentration improved by 260%, motility by 61%, and morphology (the percentage of normally shaped sperm) by 240% in men treated with letrozole.
These improvements happen because testosterone is essential for sperm production inside the testes, and the FSH boost from reduced estrogen feedback also directly supports the cells that nurture developing sperm. Research has shown that letrozole reduces DNA fragmentation in sperm and improves chromatin packaging, both of which affect whether sperm can successfully fertilize an egg and support a healthy pregnancy.
The American Urological Association and the American Society for Reproductive Medicine jointly recognize aromatase inhibitors as an option for infertile men with low testosterone, though the recommendation is conditional due to limited large-scale trial data. One double-blind trial in men with no sperm in their ejaculate found that all men in the letrozole group recovered some sperm production (compared to none in the placebo group), though no unassisted pregnancies resulted in that particular study.
Effects in Women
Letrozole raises testosterone in women too, through the same mechanism. This is relevant in two contexts. In fertility treatment, letrozole is commonly prescribed to induce ovulation in women with polycystic ovary syndrome (PCOS). The hormonal shifts it causes, including elevated LH and testosterone alongside reduced estradiol and progesterone, happen in a dose-dependent manner. For short-term ovulation induction, this is generally manageable and expected.
In prolonged use, the picture changes. Animal studies have shown that extended letrozole administration can elevate testosterone and LH to levels that actually induce PCOS-like changes, including disrupted ovarian function. This is one reason letrozole is used in short courses for fertility rather than as an ongoing therapy in women.
Bone Health and Other Tradeoffs
The testosterone increase from letrozole is generally beneficial, but the estrogen suppression that comes with it carries real risks, particularly for bones. Estrogen plays a critical role in maintaining bone density in both men and women. It’s also essential for closing growth plates in adolescents, which is why letrozole is not used casually in younger patients.
In a study of women taking letrozole after breast cancer treatment, hip bone density dropped by 3.6% and lumbar spine density dropped by 5.35% over 24 months, compared to less than 1% in the placebo group. Markers of bone breakdown were elevated as early as six months into treatment. While no patients in that study crossed the threshold for osteoporosis at the hip, a small percentage developed osteoporotic bone density in the spine.
For men using letrozole to raise testosterone, bone effects are a consideration during longer-term use. The testosterone increase itself is protective for bones, but the simultaneous estrogen depletion works against that. Men with estrogen deficiency from genetic causes consistently show low bone mineral density despite having high testosterone, which illustrates that testosterone alone isn’t enough to maintain bone health.
How Letrozole Compares to Other Options
Letrozole isn’t the only medication used to raise testosterone through hormonal feedback. Clomiphene citrate (a selective estrogen receptor modulator) works on a similar principle but through a different mechanism: instead of lowering estrogen levels, it blocks estrogen receptors in the brain, tricking the hypothalamus into thinking estrogen is low. Both approaches result in increased LH, FSH, and testosterone.
Letrozole’s advantage is that it actually lowers circulating estrogen, which can be particularly helpful for men who have elevated estradiol levels (common in obesity). Clomiphene raises both testosterone and estrogen, which may be less desirable when the testosterone-to-estradiol ratio is already out of balance. Both medications preserve the body’s own testosterone production and sperm output, unlike direct testosterone replacement therapy, which suppresses sperm production by shutting down the brain’s signaling to the testes.
For men trying to conceive, this distinction matters enormously. Exogenous testosterone acts as a male contraceptive in many cases, while letrozole actively improves sperm parameters. This is why aromatase inhibitors and similar medications are preferred over testosterone injections when fertility is a goal.